← Open Payments lookup

REBECCA VONARX: Open Payments

NPI 1831644210 · CENTRE HALL, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$610 in 35 payments from 10 companies in 2025. Trend: 2023 $411 · 2024 $1,199 · 2025 $610

Food & beverage: $610
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.10$157
Collegium Pharmaceutical, Inc.5$95
Neurocrine BioSciences, Inc.5$83
Lundbeck LLC3$61
E.R. Squibb & Sons, L.L.C.3$55
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$42
Janssen Pharmaceuticals, Inc2$36
ABBVIE INC.2$35
Teva Pharmaceuticals USA, Inc.2$31
Alkermes, Inc.1$15

Products named: REXULTI, Jornay PM, INGREZZA, ABILIFY ASIMTUFII, COBENFY, CAPLYTA, INVEGA SUSTENNA, VRAYLAR.

Industry payments across PA — which companies pay providers there.